Adults (ages 15-49) newly infected with HIV in Niger
Niger: Adults (ages 15-49) newly infected with HIV was 720 in 2024. ◆ Volatile
Adults (ages 15-49) newly infected with HIV in Niger, 1990–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
Analysis
The most recent figure for adults (ages 15-49) newly infected with hiv in Niger is 720, measured in 2024.
That represents a change of up 5.9% on the previous year and down 8.9% over ten years.
Over the whole period, adults (ages 15-49) newly infected with hiv in Niger peaked at 5,200 in 1994 and was at its lowest, 680, in 2022.
Niger ranks 77th of 140 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Adults (ages 15-49) newly infected with HIV in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 3,300 | — |
| 1991 | 4,000 | +21.2% |
| 1992 | 4,500 | +12.5% |
| 1993 | 4,900 | +8.9% |
| 1994 | 5,200 | +6.1% |
| 1995 | 5,100 | -1.9% |
| 1996 | 4,600 | -9.8% |
| 1997 | 4,300 | -6.5% |
| 1998 | 4,000 | -7.0% |
| 1999 | 3,400 | -15.0% |
| 2000 | 3,100 | -8.8% |
| 2001 | 2,800 | -9.7% |
| 2002 | 2,500 | -10.7% |
| 2003 | 2,300 | -8.0% |
| 2004 | 2,300 | +0.0% |
| 2005 | 1,900 | -17.4% |
| 2006 | 1,700 | -10.5% |
| 2007 | 1,500 | -11.8% |
| 2008 | 1,400 | -6.7% |
| 2009 | 1,100 | -21.4% |
| 2010 | 900 | -18.2% |
| 2011 | 880 | -2.2% |
| 2012 | 770 | -12.5% |
| 2013 | 750 | -2.6% |
| 2014 | 790 | +5.3% |
| 2015 | 810 | +2.5% |
| 2016 | 770 | -4.9% |
| 2017 | 740 | -3.9% |
| 2018 | 770 | +4.1% |
| 2019 | 750 | -2.6% |
| 2020 | 810 | +8.0% |
| 2021 | 740 | -8.6% |
| 2022 | 680 | -8.1% |
| 2023 | 680 | +0.0% |
| 2024 | 720 | +5.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 4,330 | 3,300 | 5,200 | 10 |
| 2000s | 2,060 | 1,100 | 3,100 | 10 |
| 2010s | 793 | 740 | 900 | 10 |
| 2020s | 726 | 680 | 810 | 5 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 15 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 1,592 (2025)
- Diphtheria - number of reported cases, per capita 0.0001 units per person (2025)
- Measles - number of reported cases, gaps filled 17,686 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is adults (ages 15-49) newly infected with hiv in Niger?
- Adults (ages 15-49) newly infected with hiv in Niger was 720 in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest adults (ages 15-49) newly infected with hiv recorded in Niger?
- The highest recorded value was 5,200 in 1994.
- What is the lowest adults (ages 15-49) newly infected with hiv recorded in Niger?
- The lowest recorded value was 680 in 2022.
- How does Niger rank for adults (ages 15-49) newly infected with hiv?
- Niger ranks 77th out of 140 countries with data for 2024.
- Is adults (ages 15-49) newly infected with hiv rising or falling in Niger?
- Over the last ten years it is down 8.9%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Adults (ages 15-49) newly infected with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of adults (ages 15-49) newly infected with HIV.